Company / PP&E per Share
Sunshine Biopharma Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.22
FY2025
5-year range
$0.00 / $38.97
FY2021-FY2025
Trend
-99.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2016 to $38.97 in FY2024.
Based on SEC 10-K filings.
0.22 in FY2025 with a 5-year CAGR of +229.9%.
Improved from $0.02 to $0.22 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- +229.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share decreased 99.4% year-over-year.
- Peak pp&e per share was recorded in FY2024.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | -99.4% |
| FY2024 | $38.97 | +240471.4% |
| FY2023 | $0.02 | -89.4% |
| FY2022 | $0.15 | +3632.2% |
| FY2021 | $0.00 | +637.2% |
| FY2020 | $0.00 | -92.7% |
| FY2019 | $0.01 | +29.2% |
| FY2018 | $0.01 | +7419.8% |
| FY2017 | $0.00 | +160.1% |
| FY2016 | $0.00 | -48.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026